TrialInternational journal of cardiology2018

The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.

Tracey G Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.